Amphenol stock reports 55 percent Q2 revenue growth
📈 Amphenol reported record Q2 2026 revenue of USD 8.8 billion, marking a 55 percent year-over-year increase driven by AI data-center demand.
💰 GAAP diluted EPS reached USD 1.37, while adjusted EPS hit USD 1.35, representing a 67 percent surge from the prior-year quarter.
📦 Orders surged to USD 10.7 billion, up 94 percent year-over-year, with a book-to-bill ratio of 1.23 to 1 indicating strong order intake.
🔮 Management guided Q3 2026 sales between USD 9.3 billion and USD 9.4 billion, implying continued double-digit growth momentum.
🤝 The CommScope integration is expected to deliver USD 4.6 billion in sales and USD 0.30 of accretion for fiscal year 2026.
📈 Goldman Sachs raised its price target to USD 116 from USD 102, maintaining a Buy rating on the stock.
📊 The average analyst 12-month price target is USD 96.85, reflecting a Moderate Buy consensus among 18 analysts.
📉 Communications-network sales are expected to decline in Q3, acting as a counter-factor to overall growth.
💵 Amphenol stock traded at USD 89.81 on October 6, 2026, with a market capitalization of USD 221.5 billion.
📅 The next scheduled earnings date is set for October 28, 2026.
- Amphenol reported record Q2 2026 revenue of USD 8.8 billion, a 55 percent year-over-year increase driven by strong demand for AI data-center infrastructure.
- Adjusted diluted EPS grew 67 percent to USD 1.35 in the second quarter, significantly outpacing revenue growth and demonstrating operational leverage.
- Orders jumped 94 percent year-over-year to USD 10.7 billion, with a book-to-bill ratio of 1.23 indicating robust order intake relative to sales.
- Management raised Q3 guidance expectations, projecting sales between USD 9.3 billion and USD 9.4 billion with adjusted EPS growth of 51-53 percent.
- The CommScope integration is accelerating value creation, now expected to contribute USD 4.6 billion in sales and USD 0.30 of accretion for fiscal year 2026.
- Goldman Sachs raised its price target to USD 116 from USD 102 while maintaining a Buy rating, citing the company's strong AI exposure.
- The broader analyst consensus is Moderate Buy with an average 12-month price target of USD 96.85, suggesting upside potential from current levels.
- The stock is trading at USD 89.81, which is below the revised Goldman Sachs target of USD 116 and the average analyst target of USD 96.85.